(Q40690046)

22 September 2017

title

K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement (English)

1 reference

22 September 2017

K Jurianz

1

1 reference

22 September 2017

S Ziegler

2

1 reference

22 September 2017

N Donin

3

1 reference

22 September 2017

Y Reiter

4

1 reference

22 September 2017

Z Fishelson

5

1 reference

22 September 2017

M Kirschfink

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

International Journal of Cancer

22 September 2017

published in

1 reference

22 September 2017

volume

93

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

848-854

1 reference

Protection of thyroid cancer cells by complement-regulatory factors

22 September 2017

cites work

1 reference

Experimental tumoricidal effects of monoclonal antibody against solid breast tumors

21 January 2018

1 reference

Immune evasion of tumor cells using membrane-bound complement regulatory proteins

21 January 2018

1 reference

The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium

21 January 2018

1 reference

Sublytic complement attack protects tumor cells from lytic doses of antibody and complement

21 January 2018

1 reference

Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP).

21 January 2018

1 reference

Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay

21 January 2018

1 reference

CRYSTALLINE SOYBEAN TRYPSIN INHIBITOR : II. GENERAL PROPERTIES.

21 January 2018

1 reference

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

21 January 2018

1 reference

Complement resistance of tumor cells: basal and induced mechanisms.

21 January 2018

1 reference

Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium

21 January 2018

1 reference

Complement-regulatory proteins in ovarian malignancies

21 January 2018

1 reference

Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies

21 January 2018

1 reference

The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29.

21 January 2018

1 reference

Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line

21 January 2018

1 reference

Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity

21 January 2018

1 reference

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

21 January 2018

1 reference

Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells

21 January 2018

1 reference

Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand

21 January 2018

1 reference

Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma

21 January 2018

1 reference

Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2

21 January 2018

1 reference

Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A

21 January 2018

1 reference

Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity

21 January 2018

1 reference

Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL)

21 January 2018

1 reference

Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines

21 January 2018

1 reference

Decay-accelerating factor is a component of subendothelial extracellular matrix in vitro, and is augmented by activation of endothelial protein kinase C

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1406

1 reference

22 September 2017

1 reference